Suppression of pulmonary metastasis by angiogenesis inhibitor TNP-470 in murine osteosarcoma
- 29 March 1995
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 61 (1) , 148-152
- https://doi.org/10.1002/ijc.2910610125
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parentPublished by Elsevier ,2004
- Assay of the antiangiogenic compound TNP-470, and one of its metabolites, AGM-1883, by reversed-phase high-performance liquid chromatography in plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1994
- Analysis of experimental antiangiogenic therapyJournal of Pediatric Surgery, 1993
- Chemical Modification of Fumagillin. I. 6-O-Acyl, 6-O-Sulfonyl, 6-O-Alkyl, and 6-O-(N-Substituted-carbamoyl)fumagillols.CHEMICAL & PHARMACEUTICAL BULLETIN, 1992
- Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthNature, 1990
- Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related PeptidesScience, 1990
- Thoracotomy for pulmonary metastatic osteosarcoma. An analysis of prognostic indicators of survivalCancer, 1987
- Angiogenesis Inhibition and Tumor Regression Caused by Heparin or a Heparin Fragment in the Presence of CortisoneScience, 1983
- The pathogenesis of cancer metastasisNature, 1980
- Transplacental Carcinogenesis by StilbestrolNew England Journal of Medicine, 1971